Knight Therapeutics | GUD - 流动负债

股票价格

7.45

每天变化

0.01 0.13%

每月一次

19.58%

每年

22.13%

Q2 预测

7.26

金融业

CAD

CAD 1.05B

现金及等价物

CAD 76.45M

CAD 82.22M

CAD 394.84M

CAD 165.26M

CAD 77.91M

CAD 6.21M

CAD 24.45M

698

EPS每股收益

CAD -0.09

股本和储备

CAD 767.27M

CAD 64.72M

债务利息支出

CAD 3.92M

CAD 2.46M

CAD 57.78M

CAD 753.72M

CAD -3.79M

CAD 126.9M

CAD 6.21M

普通股股本

CAD 99.68M

257.34

CAD -1.92M

CAD 133.11M

销售和管理费用

CAD 35.45M

CAD 95.4M

贸易债权人

CAD 125.76M

应收帐款人

CAD 183M

	流动负债	更改		日
Acasti Pharma	USD 1.24M		1.08M	2025-09
Akebia Therapeutics	USD 162.94M		29.56M	2025-12
Alaunos Therapeutics	USD 921K		153K	2025-09
Aurora Cannabis	CAD 145.94M		21.82M	2025-12
Avita Medical	AUD 62.68M		77K	2025-12
Canopy Growth	CAD 98.29M		17.19M	2025-12
Cronos Group	USD 48.19M		7.12M	2025-12
Dianthus Therapeutics	USD 30.73M		6.88M	2025-12
Ionis Pharmaceuticals	USD 783M		120.46M	2025-12
IQVIA Holdings	USD 8.34B		170M	2025-12
Knight Therapeutics	CAD 165.26M		12.58M	2025-12
Moderna	USD 1.99B		306M	2025-12
Omeros	USD 85.5M		2.28M	2025-06
Organigram Holdings	CAD 94.05M		32.11M	2025-12
Organon & Co	USD 2.68B		117M	2025-09
Revvity	USD 1.33B		108.5M	2025-12
Tectonic Therapeutic	USD 9.67M		293K	2025-12
Tilray	USD 259.32M		8.32M	2025-09
Viatris	USD 7.09B		269.8M	2025-12
Xeris Pharmaceuticals	USD 109.57M		6.63M	2025-12